Market Tracker

04/17 6:02pm ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.725
Delayed Data
As of Apr 17
 +0.025 / +3.57%
Today’s Change
0.68
Today|||52-Week Range
4.30
-54.69%
Year-to-Date

Today’s Trading

Previous close0.70
Today’s open0.80
Day’s range0.71 - 0.80
Volume4,369,209
Average volume (3 months)736,913
Market cap$22.6M
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+72.57%
Earnings growth (this year)+56.33%
Earnings growth (next 5 years)--
Revenue growth (last year)-82.21%
P/E ratioNM
Price/Sales368.74
Price/Book13.66

Competitors

 Today’s
change
Today’s
% change
CANFCan Fite Biopharma L...-0.01-0.47%
CBMXCombiMatrix Corp-0.04-2.12%
ICCCImmuCell Corp-0.13-2.10%
WGBSWaferGen Bio-systems...+0.11+2.38%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateMay 13, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$71.0K
Annual profit (last year)-$8.8M
Net profit margin-12,394.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Westborough, Massachusetts

Forecasts